PDF
(Download)
|
- Coffee (Coffea arabica)
- Grape (Vitis vinifera) Seed Extract
- Cognition
- Brain-derived Neurotrophic Factor (BDNF)
|
Date:
05-31-2013 | HC# 021324-473
|
Re: Levels of a Brain Protein Involved in Cognition Increased with Whole Coffee Fruit Concentrate Powder Supplementation
Reyes-Izquierdo
T, Nemzer B, Shu C, et al. Modulatory effect of coffee fruit extract on plasma
levels of brain-derived neurotrophic factor in healthy subjects. Br J Nutr. January 14, 2013:1-6. [epub
ahead of print]. doi: 10.1017/S0007114512005338.
Brain-derived
neurotrophic factor (BDNF) is a secreted protein that is involved in the development,
maintenance, and function of the central nervous system, where it plays an important
role in learning, memory, and behavior. It is also found in the tissues of a
number of systems, including the cardiovascular, immune, reproductive, and
endocrine systems. It has been shown that polyphenol-rich natural products also
containing caffeine can increase plasma levels of BDNF. This controlled, pilot,
acute study tested the effects of 4 such products – caffeine from green coffee
(Coffea arabica), green coffee bean
extract, whole coffee fruit concentrate powder (WCFC), and grape (Vitis vinifera) seed extract (containing
high levels of polyphenols, but no caffeine) – in healthy subjects.
Twenty-five healthy,
non-smoking subjects who were 18-55 years of age and who were not taking any
drugs or supplements were randomly allocated to 1 of the 5 treatments (n=5 for each)
following a 12-hour fast: green coffee caffeine (N677; 72.8% caffeine); green
coffee bean extract (N625; 2% caffeine); WCFC (0.7% caffeine); grape seed extract
(N31; 0% caffeine); or placebo (silica dioxide; 0% caffeine). No intake amounts
were provided. Funding was provided by FutureCeuticals, Inc. (Momence,
Illinois), the assumed manufacturers. The subjects received no other food or
drink during the course of the study. Blood was collected at baseline and 30,
60, 90, and 120 minutes after treatment intake.
WCFC significantly
increased BDNF compared to placebo (P=0.001), as well as compared to its own
baseline, by 137%. None of the other treatments increased BDNF significantly.
The placebo decreased
BDNF by 34%, which has not previously been reported. Therefore, the authors
repeated the acute intake of WCFC in 15 new subjects who also fit the
inclusion/exclusion criteria. The subjects received either 50 mg of chlorogenic
acid, 100 mg of WCFC, or placebo (n=5 for each). BDNF increased significantly
in the WCFC group (P<0.05), but not in the other 2 groups.
The authors suggest
that the results of this study show that BDNF levels are not influenced by either
caffeine or polyphenols, as has been shown in the past, but rather, by
procyanidins or the unique coffee profile of WCFC.
—Risa Schulman,
PhD
Peer
Reviewer Comments:
An expert peer reviewer of
this HerbClip has written the following about this study: The statistical power
of the study is in question, given that 40 subjects would be required to reach
a power calculation of 80%. The
reviewer also noted one dose means very little; repetitive use could have
provided further information. Again, such multiple dosing presumably could be
done in a larger, follow-up trial.
Originally published June 15, 2013. Revised July 14, 2013 and on September 10, 2013.
|